Responsive Image Banner

Theiss takes lead on Pacific Highway contract

Premium Content

24 November 2012

Australia’s Thiess, in a joint venture with MacMahon Contractors, has been named as the preferred contractor on the Pacific Highway upgrade between Frederickton Interchange and Eungai in New South Wales.

The Thiess MacMahon joint venture (TMJV) – in which Theiss is the lead partner with 60% - is to design and construct a 26.5 km four-lane divided carriageway.

The contractor, a wholly-owned subsidiary of Leighton Holdings Limited, is also currently working on the Hunter Expressway near Newcastle, also in New South Wales.

The contract, awarded by the Federal and NSW State Governments, will be signed in December and while the value is yet to be finalised, it is expected to be in the order of AU$450 million (US$ 470 million).

STAY CONNECTED

Receive the information you need when you need it through our world-leading magazines, newsletters and daily briefings.

Sign up

Longer reads
Update: What do world’s biggest construction firms now spend on R&D?
The world’s largest construction companies continue to spend huge sums R&D. But how much exactly?
Project report: Robot used for power plant demolition
Sarens and Tadano carry out Dutch demolition project
Are humanoid robots really coming to a construction work site near you?
Robots have been threatening to take over work on construction sites for the past several years and haven’t. Will they eventually?
CONNECT WITH THE TEAM
Andy Brown Editor, Editorial, UK - Wadhurst Tel: +44 (0) 1892 786224 E-mail: [email protected]
Neil Gerrard Senior Editor, Editorial, UK - Wadhurst Tel: +44 (0) 7355 092 771 E-mail: [email protected]
Eleanor Shefford Brand Manager Tel: +44 (0) 1892 786 236 E-mail: [email protected]
Peter Collinson International Sales Manager Tel: +44 (0) 1892 786220 E-mail: [email protected]
CONNECT WITH SOCIAL MEDIA
Construction technology survey

Share your views and we’ll give to charity!

Take a quick survey on how you research equipment and we’ll donate £1 to Macmillan Cancer Support for every response.

Take the Survey